亚川 ADTN 深 沪
已收盘 05-15 16:00:00 美东时间
14.91
-0.370
-2.42%
华盛通- 最 高15.09
- 今 开14.83
- 成交量 194.04万股
- 最 低 14.71
- 昨 收 15.28
- 总市值 120.77万
- 52周最高 18.69
- 市盈率 静 --
- 换手率 2395.62%
- 52周最低 7.11
- 委 比 -7.37%
- 总股本 8.10万
- 历史最高 35.71
- 量 比 0.89
- 振 幅 2.49%
- 历史最低 3.54
- 每 手 1
- 风险率 2.42%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Adtran CTO Christoph Glingener sells 126,115 shares for USD 1.89 million
Adtran CTO Christoph Glingener sells 126,115 shares for USD 1.89 million ADTRAN Chief Technology Officer Christoph Glingener sold 126,115 shares. Sale executed May 7, 2026 on Nasdaq. Shares sold at multiple prices around USD 14.73 to USD 15.69. Total proceeds amounted to USD 1.89 million at an avera
05-13 22:56
Adtran Networks Q1 FY26 net loss narrows 78.5% to EUR 3.46 million
Adtran Networks Q1 FY26 net loss narrows 78.5% to EUR 3.46 million Adtran Networks posted Q1 2026 revenue of EUR 117.46 million, up 2.9%, while net loss narrowed to EUR 3.46 million. Operating loss tightened to EUR 2.3 million, with savings initiatives cited as driving lower operating expenses. Pro
05-12 17:51
美股大行评级 | 绩后暴跌10%，ARM仍获高盛、富国银行等多家大行上调目标价；康宁、优步、飞塔信息、西维斯、Agilon Health等获多家大行上调目标价
今日重点评级关注：Citizens：维持BioCryst制药"跑赢大市"评级，目标价从25美元升至28美元；富国银行：维持曼恩凯德生物医疗"超配"评级，目标价从8美元升至10美元
05-08 12:05
美股大行评级 | 潜在涨幅20%！15家机构集体上调AMD目标价；Lumentum、神经分泌生物科学、伊顿公司、美国电力等获多家大行上调目标价
今日重点评级关注：Citizens：维持Avalo Therapeutics"跑赢大市"评级，目标价从52美元升至62美元；BTIG：维持Avalo Therapeutics"买入"评级，目标价从40美元升至58美元
05-07 12:37
Needham Reiterates Buy on Adtran Holdings, Maintains $18 Price Target
Needham analyst Ryan Koontz reiterates Adtran Holdings (NASDAQ:ADTN) with a Buy and maintains $18 price target.
05-06 18:54
Adtran Networks announces annual general meeting
Adtran Networks announces annual general meeting Adtran Networks SE scheduled annual general meeting for June 15, 2026 in Munich. Shareholders to vote on proposal to carry forward full net profit of EUR 177,438,127.08, despite distribution cap of EUR 96,430,619.07 cited in meeting materials. Ballots
05-06 16:04
ADTRAN Holdings shares are trading lower. The company reported Q1 financial results.
ADTRAN Holdings shares are trading lower. The company reported Q1 financial res...
05-05 21:24
Full Transcript: Adtran Holdings Q1 2026 Earnings Call
Adtran Holdings (NASDAQ:ADTN) released first-quarter financial results and host...
05-05 21:16
GeneDx Holdings, Duolingo, Kosmos Energy And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Dow futures up 100 pts. Shares of GeneDx Holdings (WGS) down 39.2% after cutting FY26 sales guidance. Other stocks falling in pre-market trading.
05-05 20:02
Adtran Holdings Sees Q2 Sales $283.000M-$303.000M vs $293.022M Est
For the second quarter of 2026, the Company expects revenue to be within a range of $283.0 million to $303.0 million. Non-GAAP operating margin is expected to be within a range of 5.0% to 9.0%.
05-05 13:36
